Showing results (101-110 of 206) with videos related to
Sort By:
Pageof 21
Clinical & Experimental Metastasis|July 1, 1994
Aberrations of growth factor control in metastatic follicular thyroid cancer in vitroT Hoelting, A Zielke, A E Siperstein, et al.Thyroid : Official Journal of the American Thyroid Association|February 1, 1995
Biphasic effects of thyrotropin on invasion and growth of papillary and follicular thyroid cancer in vitroT Hoelting, S Tezelman, A E Siperstein, et al.The Journal of Surgical Research|February 1, 1985
Estrogen and thyroid-stimulating hormone (TSH) receptors in neoplastic and nonneoplastic human thyroid tissueO H Clark, P L Gerend, M Davis, et al.The Journal of Clinical Endocrinology and Metabolism|August 12, 1999
Phenylacetate inhibits growth and vascular endothelial growth factor secretion in human thyroid carcinoma cells and modulates their differentiated functionE Kebebew, M G Wong, A E Siperstein, et al.Cancer|March 4, 2000
Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systemsE Kebebew, P H Ituarte, A E Siperstein, et al.Surgery|December 1, 1989
TSH binding correlates with TSH-stimulated thyroid adenylate cyclase activity in human thyroid tissuesQ Y Duh, A E Siperstein, R A Miller, et al.Radiology|October 1, 1987
Parathyroid variants: US evaluationS B Randel, G A Gooding, O H Clark, et al.Surgery|December 1, 1993
Thyroid-stimulating hormone activates phospholipase C in normal and neoplastic thyroid tissueJ K Shaver, S Tezelman, A E Siperstein, et al.American Journal of Surgery|October 1, 1990
Results of surgical treatment for hyperparathyroidism associated with renal diseaseM J Demeure, D C McGee, W Wilkes, et al.Archives of Surgery (Chicago, Ill. : 1960)|October 1, 1992
Normocalcemic hyperparathyroidism. Biochemical and symptom profiles before and after surgeryA E Siperstein, W Shen, A K Chan, et al.Pageof 21